๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target?

โœ Scribed by Ricky W Johnstone; Jonathan D Licht

Book ID
114413325
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
195 KB
Volume
4
Category
Article
ISSN
1535-6108

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Histone Deacetylase Inhibitors in Cancer
Histone Deacetylase Inhibitors in Cancer Therapy
โœ Lane, Andrew A. (author);Chabner, Bruce A. (author) ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› American Society of Clinical Oncology ๐ŸŒ English โš– 156 KB
Histone Deacetylase Inhibitors in Cancer
Histone Deacetylase Inhibitors in Cancer Therapy
โœ Lane, Andrew A. (author);Chabner, Bruce A. (author) ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› American Society of Clinical Oncology ๐ŸŒ English โš– 156 KB
Targeting Histone Deacetylase in Cancer
Targeting Histone Deacetylase in Cancer Therapy
โœ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons โš– 8 KB ๐Ÿ‘ 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Targeting histone deacetylase in cancer
Targeting histone deacetylase in cancer therapy
โœ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB

## Abstract Histone deacetylase (HDAC) is recognized as one of the promising targets for cancer treatment as many HDAC inhibitors have entered clinical trials for both solid and liquid tumors. Nevertheless, the mechanisms underlying the antiproliferative effects of HDAC inhibitors remain elusive. A